Laura Melotti - Publications

Effectiveness and safety of mirikizumab in multirefractory ulcerative colitis: analysis from a real-world cohort.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: March 28, 2026

From trial to real life: ten-year impact of a nutraceutical strategy on duodenal polyp burden in familial adenomatous polyposis.

Journal: Frontiers in oncology

Published: July 30, 2025

Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis?

Journal: Microbiology spectrum

Published: October 14, 2024

Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients.

Journal: Frontiers in cellular and infection microbiology

Published: December 07, 2023

The contribution of ultrasound in the diagnostic pathway of a symptomatic hepatocellular adenoma arising from ectopic liver.

Journal: Journal of ultrasound

Published: November 18, 2023

Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study.

Journal: The American journal of gastroenterology

Published: August 17, 2023

Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 22, 2022

COVID-19 in IBD: The experience of a single tertiary IBD center.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 26, 2020